Bio Green Med Solution (BGMS) Revenue Growth (3y) (2013 - 2026)
Powered by 
Analysis
Bio Green Med Solution (BGMS) Revenue Growth (3y) (2013 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 141.56 Bn | 133.71 Bn | 2.84 Bn | 10.17% |
| 2 | Regeneron Pharmaceuticals | 87.63 Bn | 79.64 Bn | 3.93 Bn | 10.76% |
| 3 | Argenx Se | 64.65 Bn | 59.46 Bn | 1.37 Bn | 77.85% |
| 4 | Moderna | 60.24 Bn | 55.10 Bn | 52.00 Mn | -25.02% |
| 5 | Revolution Medicines | 44.13 Bn | 44.13 Bn | - | - |
| 6 | BeOne Medicines | 40.46 Bn | 35.36 Bn | 1.53 Bn | 42.02% |
| 7 | Alnylam Pharmaceuticals | 35.86 Bn | 32.56 Bn | 992.69 Mn | 59.40% |
| 8 | Royalty Pharma | 28.00 Bn | 27.16 Bn | - | 7.80% |
| 9 | Insmed | 27.40 Bn | 26.24 Bn | 358.27 Mn | 76.62% |
| 10 | Bio Green Med Solution | 4.68 Mn | 886,595.10 | 79,000.00 | -3.42% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -3.42% |
| Dec 31, 2018 | -29.11% |
| Dec 31, 2016 | -2.52% |
| Sep 30, 2016 | -12.78% |
| Jun 30, 2016 | -5.61% |
| Mar 31, 2016 | -13.13% |
| Dec 31, 2015 | 338.30% |
| Sep 30, 2015 | 165.97% |
| Jun 30, 2015 | 124.96% |
| Mar 31, 2015 | 47.06% |
| Dec 31, 2014 | 12.17% |
| Sep 30, 2014 | 64.87% |
| Jun 30, 2014 | 28.44% |
| Mar 31, 2014 | 27.29% |
| Dec 31, 2013 | 39.00% |
| Sep 30, 2013 | 24.79% |
| Jun 30, 2013 | 30.42% |